You're viewing a public preview of Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility

Inactive
Gaithersburg,  Maryland (MD),  United States
Sector: Life Science Entity: Private
Merged Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility merged into BioNTech AG in 2021
1
Transactions
Sign up to view
About Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility
Within the Acquity Data private market database, Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility operates in the Life Science sector. It is active in the Life Science space. The company is headquartered in Gaithersburg, Maryland (MD). Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility appears in Acquity Data's private market intelligence platform.
Investors
Current Investors
BioNTech AG ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
1 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 1 Transaction
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility do?
Within the Acquity Data private market database, Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility operates in the Life Science sector. It is active in the Life Science space. The company is headquartered in Gaithersburg, Maryland (MD). Kite Pharma - Neoantigen TCR Cell
Where is Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility headquartered?
Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility is headquartered in Gaithersburg, Maryland (MD), United States.
When was Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility founded?
Founded year information for Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility is available on AcquityData.
What sector is Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility in?
Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility operates in the Life Science sector.
Who are the investors in Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility?
Current investors in Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility include BioNTech AG. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility been involved in?
Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility has 1 transaction tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial